This shows there is no difference in the progression to PIN in prostates that have lost Pten and those that have lost both Pten and Ctnnb1, suggesting that β-Catenin does not play a role in Pten loss-driven prostate cancer. The gene discussed is PTEN; the disease is prostate carcinoma.